Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Colorectal Neoplasms × Nivolumab × Clear all

Phase

Status

Sponsor Class

INDUSTRY 35 OTHER 25 NIH 3 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hodgkin Disease 2 Recurrent Squamous Cell Lung Carcinoma 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Gastric and Esophagogastric Junction Adenocarcinoma 1 Colorectal Neoplasms 1 Carcinoma 1 Advanced Solid Tumors 1 Adenocarcinoma 1

Interventions

Fluorouracil 26 Oxaliplatin 24 Leucovorin 23 Capecitabine 15 Irinotecan 13 Radiotherapy 8 Bevacizumab 8 Cetuximab 7 Folfox protocol 4 Panitumumab 3 tremelimumab 2 neratinib 2 napabucasin 2 durvalumab 2 cediranib 2 aflibercept 2 X-Rays 2 Surgical Procedures, Operative 2 Radiofrequency Ablation 2 Psychiatric Rehabilitation 2 Preoperative Exercise 2 Octreotide 2 Mitomycin 2 Levamisole 2 Interviews as Topic 2 Folic Acid 2 Floxuridine 2 Counseling 2 Cisplatin 2 Celecoxib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03647839 2021-08-27

MODULATE

Australasian Gastro-Intestinal Trials Group

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡